In this videobased module expert faculty reviews the safety profiles of the FDAapproved CSF1R inhibitors pexidartinib and vimseltinib for tenosynovial giant cell tumor TGCT The faculty also highlights common and clinically important adverse events including hepatotoxicity periorbital edema rash pruritus gastrointestinal toxicities and laboratory abnormalities as well as differences between the agents Patient counseling laboratory monitoring supportive care treatment interruption dose reduction and permanent discontinuation strategies are also addressed to help healthcare professionals balance treatment efficacy with safety and quality of life in patients with TGCT
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
98% of listed courses are free
294 of a sample of 300 are free · 531 courses listed here.
Collected from the provider’s public pages · source
Specialties served/covered
- Addiction Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Clinical Informatics
- Clinician Wellness & Burnout
- Communication & Shared Decision-Making
- Critical Care Medicine
- Dermatology
- Diagnostic Radiology
- Emergency Medicine
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Geriatric Psychiatry
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Laryngology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Obstetrics & Gynecology
- Otology & Neurotology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Otolaryngology
- Psychopharmacology
- Psychotic Disorders
- Pulmonary Disease
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Cardio-Vascular
- Cross-Specialty
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- On-demand / recorded video
- includes Online course / module
- Credit · Up to 0.25 credits
- MOC · Up to 0.25 points
- Commercial Support
-
ReleasedAug 25, 2026
-
Last day to claim creditFeb 25, 2027 5 months left
-
PRIME Education, Inc. (PRIME®) Real-World Strategies to Improve Multidisciplinary Care Coordination of TGCT
-
Global Learning Collaborative Beyond the Joint: Cross-Specialty Solutions for Advancing TGCT Patient Care
-
Physicians’ Education Resource Practical Strategies for Monitoring and Managing Toxicities With Novel Therapies for HER2-Positive Gastroesophageal Adenocarcinoma
-
Clinical Care Options, LLC (dba Decera Clinical Education) Applying the Latest Data and Expert Guidance for CSF1R-Targeted Treatment of TGCT
-
Smart Patients +1 Adverse Management and Supportive Care in Myelofibrosis Treatment
-
Clinical Care Options, LLC (dba Decera Clinical Education) Precision Diagnosis and Disease Biology of TGCT Establishing the Rationale for CSF1R Targeting
